Aarti Drugs Limited (BOM:524348)

Aarti Drugs Statistics

Total Valuation

Aarti Drugs has a market cap or net worth of INR 33.88 billion. The enterprise value is 39.37 billion.

Market Cap	33.88B
Enterprise Value	39.37B

Important Dates

The last earnings date was Friday, January 23, 2026.

Earnings Date	Jan 23, 2026
Ex-Dividend Date	Feb 9, 2026

Share Statistics

Aarti Drugs has 91.27 million shares outstanding. The number of shares has decreased by -0.18% in one year.

Current Share Class	91.27M
Shares Outstanding	91.27M
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	-7.68%
Owned by Insiders (%)	48.38%
Owned by Institutions (%)	19.28%
Float	34.40M

Valuation Ratios

The trailing PE ratio is 16.73 and the forward PE ratio is 16.61. Aarti Drugs's PEG ratio is 0.72.

PE Ratio	16.73
Forward PE	16.61
PS Ratio	1.34
PB Ratio	2.31
P/TBV Ratio	2.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.72

Enterprise Valuation

EV / Earnings	19.44
EV / Sales	1.56
EV / EBITDA	13.12
EV / EBIT	16.21
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.39
Debt / EBITDA	1.91
Debt / FCF	n/a
Interest Coverage	7.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.51%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.10%
Revenue Per Employee	19.64M
Profits Per Employee	1.58M
Employee Count	1,284
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Aarti Drugs has paid 92.54 million in taxes.

Income Tax	92.54M
Effective Tax Rate	4.37%

Stock Price Statistics

The stock price has decreased by -4.66% in the last 52 weeks. The beta is 0.13, so Aarti Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-4.66%
50-Day Moving Average	390.78
200-Day Moving Average	455.74
Relative Strength Index (RSI)	43.66
Average Volume (20 Days)	6,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aarti Drugs had revenue of INR 25.22 billion and earned 2.03 billion in profits. Earnings per share was 22.18.

Revenue	25.22B
Gross Profit	8.94B
Operating Income	2.43B
Pretax Income	2.12B
Net Income	2.03B
EBITDA	2.99B
EBIT	2.43B
Earnings Per Share (EPS)	22.18

Balance Sheet

The company has 245.40 million in cash and 5.73 billion in debt, with a net cash position of -5.49 billion or -60.15 per share.

Cash & Cash Equivalents	245.40M
Total Debt	5.73B
Net Cash	-5.49B
Net Cash Per Share	-60.15
Equity (Book Value)	14.69B
Book Value Per Share	148.52
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 35.46%, with operating and profit margins of 9.63% and 8.03%.

Gross Margin	35.46%
Operating Margin	9.63%
Pretax Margin	8.39%
Profit Margin	8.03%
EBITDA Margin	11.86%
EBIT Margin	9.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.53%.

Dividend Per Share	2.00
Dividend Yield	0.53%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.18%
Shareholder Yield	0.71%
Earnings Yield	5.98%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2